Literature DB >> 11531681

Effect of ondansetron pretreatment on pain after rocuronium and propofol injection: a randomised, double-blind controlled comparison with lidocaine.

M S Reddy1, F G Chen, H P Ng.   

Abstract

In a randomised, controlled, double-blinded trial to study the effect of ondansetron pretreatment on the pain produced after intravenous injection of rocuronium and propofol in comparison with lidocaine, 60 patients were randomly assigned to one of three groups. Group 1 received 5 ml of intravenous 0.9% sodium chloride solution pretreatment, group 2 received ondansetron 4 mg (2 mg.ml-1 solution) diluted into a 5-ml solution, and group 3 received 50 mg lidocaine (5 ml 1% solution); this was followed 1 min later by rocuronium and propofol. Pain was reduced significantly in the ondansetron and lidocaine groups (p < 0.0001) compared with placebo, and significantly better with lidocaine than with ondansetron (p = 0.02). We conclude that ondansetron is effective in relieving the pain of rocuronium but is not as effective as lidocaine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11531681     DOI: 10.1046/j.1365-2044.2001.02059-6.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  26 in total

Review 1.  5-HT3 Receptor Antagonists for Propofol Injection Pain: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Wen Wang; Liang Zhou; Lin-Xin Wu; Tong Wang; Chao-Bing Zhang; Li Sun
Journal:  Clin Drug Investig       Date:  2016-04       Impact factor: 2.859

2.  Effect of narcotic pretreatment on pain after rocuronium injection: a randomized, double-blind controlled comparison with lidocaine.

Authors:  Mukta Singh; Himanshu Chauhan; Girija P Rath; Hemanshu Prabhakar; Parmod K Bithal; Hari H Dash
Journal:  J Anesth       Date:  2007-11-01       Impact factor: 2.078

3.  Preventive effect of a vapocoolant spray on propofol-induced pain: a prospective, double-blind, randomized study.

Authors:  Young Eun Moon; Michael Y Lee; Dong Hyun Kim
Journal:  J Anesth       Date:  2017-08-05       Impact factor: 2.078

4.  Pretreatment with nafamostat mesilate, a kallikrein inhibitor, to decrease withdrawal response associated with rocuronium.

Authors:  Yoon Hee Kim; Young Kwon Go; Jung Un Lee; Woo Suk Chung; Yong Sup Shin; Kyu Cheol Han; Ji Eun Shin; Suk Hoon Lee
Journal:  J Anesth       Date:  2010-05-25       Impact factor: 2.078

5.  Magnesium sulfate with lidocaine for preventing propofol injection pain: a randomized, double-blind, placebo-controlled trial.

Authors:  Richard E Galgon; Peter Strube; Jake Heier; Jeremy Groth; Sijian Wang; Kristopher M Schroeder
Journal:  J Anesth       Date:  2014-08-06       Impact factor: 2.078

6.  The influence of age and gender on remifentanil EC(50) for preventing rocuronium induced withdrawal movements.

Authors:  So Jin Park; Hye Jin Park; Ju Youn Choi; Hyo Seok Kang; Hong Seok Choi
Journal:  Korean J Anesthesiol       Date:  2010-03-29

7.  Prevention of Withdrawal Movement Associated with the Injection of Rocuronium in Children: Comparison of Paracetamol and Lidocaine.

Authors:  Reyhan Polat; Mine Akın; Gülsen Keskin; Dilek Ünal; Aslı Dönmez
Journal:  Turk J Anaesthesiol Reanim       Date:  2016-04-01

Review 8.  Lidocaine for reducing propofol-induced pain on induction of anaesthesia in adults.

Authors:  Pramote Euasobhon; Sukanya Dej-Arkom; Arunotai Siriussawakul; Saipin Muangman; Wimonrat Sriraj; Porjai Pattanittum; Pisake Lumbiganon
Journal:  Cochrane Database Syst Rev       Date:  2016-02-18

Review 9.  Pharmacological prevention of rocuronium-induced injection pain or withdrawal movements: a meta-analysis.

Authors:  Hyun Jeong Kwak; Ji Young Kim; Yong Beom Kim; Sang Kee Min; Bong Ki Moon; Jong Yeop Kim
Journal:  J Anesth       Date:  2013-03-22       Impact factor: 2.078

10.  Efficacy of different fluids preload on propofol injection pain: A randomized, controlled, double-blinded study.

Authors:  Shi-Ying Yuan; Tian-Yuan Luo; Zhen Liu; Yun Lin
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.